Side-by-side comparison of AI visibility scores, market position, and capabilities
Acquired by LetsGetChecked August 2024 for $525M; $322M total funding; $66.2M Series D August 2023; $1.6B valuation; 1M+ prescriptions processed
Truepill is a digital pharmacy infrastructure provider that enables healthcare companies, telehealth platforms, and retailers to offer pharmacy services through white-label fulfillment and technology solutions. The company serves digital health startups, health systems, retailers, and telemedicine providers who want to integrate prescription fulfillment into their offerings without building pharmacy infrastructure. Truepill operates a nationwide network of licensed pharmacies and provides end-to-end pharmacy services including prescription processing, medication dispensing, and direct-to-patient delivery.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.